RT @CancerCareMASCC: Risk of severe #hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and com…
3,837 followers
82 followers
9,176 followers
RT @CancerCareMASCC: Risk of severe #hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and com…
1,322 followers
1,366 followers
RT @CancerCareMASCC: Risk of severe #hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and com…
5,112 followers
Risk of severe #hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials https://t.co/ujQ7Su6lW3 This is one of the #MASCC18 abstract topics, share your research too